Die Studie

Die Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.

Study of a new compound that is being developed for the treatment of inflammatory diseases.

  • You are a male or female between 18 and 64 years old

  • You do not smoke

  • Your body weight must be at least 50 kg and your Body Mass Index (BMI) is between 18.5 and 30.0 kg/m2. The BMI shows the relation between body weight in kilograms and height in meters.

  • As a male you are only allowed to participate in this study if you use sufficient contraception measures (a condom in combination with a female contraception method) or if you are surgically sterilized. 

  • As a female you are only allowed to participate in this study if

    • you use sufficient non-hormonal contraception used (a copper IUD);

    • do total abstinence (when this is your lifestyle);

    • you are surgically sterilized or if you are postmenopausal for at least 1 year. 

  • To determine if you are suitable to participate in this study, you will undergo a medical screening. 

Zeitraum

For groups 4 and higher in Part C you will stay for 18 days (17 nights).

There will be a follow-up visit 7 to 10 days after the (last) administration.

Group stay
C5a 15 Nov 2020 up to and including 2 Dec 2020

Follow-up by appointment between 06 - 09 October 2020 (C4e).

Nakeuring op afspraak tussen 07 - 10 december 2020 (C5a).

Please note: You have to be available for all dates for the group of choice to be able to participate in this study. The actual dates will be published on our website. These are the currently planned dates; however, these may be subject to change.

Aufwandsentschädigung

For participation in one of the groups of part C of the study, you will receive a gross compensation of € 2.896,-.

Travelling expenses will be reimbursed based on the distance traveled (€0.19 net per kilometer) with a minimum of €12.- and a maximum of €160.- (840 kilometers) per return, regardless of the mode of transportation.